亚太药业：关于注销子公司的公告

Group 1 - The core point of the article is that Asia-Pacific Pharmaceutical announced the decision to dissolve its wholly-owned subsidiary, Wuhan Guanggu Asia-Pacific Pharmaceutical Co., Ltd., during the fifth meeting of the eighth board of directors held on October 13, 2025 [1] Group 2 - The decision to dissolve the subsidiary was formally approved in the board meeting [1] - The announcement was made on the evening of October 13 [1]